Reyon Pharmaceutical Co Ltd Capital Reinvestment Ratio
Reyon Pharmaceutical Co Ltd capital reinvestment ratio. Reyon Pharmaceutical Co Ltd (102460) has a Capital Reinvestment Ratio of 1.76x as of March 2025, meaning it reinvests 2% of its operating cash flow (₩2.41 Billion) in capital expenditures (₩4.25 Billion). See free cash flow generation of Reyon Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Reyon Pharmaceutical Co Ltd (2008–2023)
Capital reinvestment ratio of Reyon Pharmaceutical Co Ltd from 2008 to 2023. This chart tracks Reyon Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 11 annual periods. See financial flexibility index of Reyon Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Reyon Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2008–2023)
Reyon Pharmaceutical Co Ltd capital reinvestment ratio by year from 2008 to 2023. For the full cash flow conversion analysis, see cash flow conversion of Reyon Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 3.34x | ₩8.65 Billion | ₩28.87 Billion | ▼ -53.8% |
| 2022 | 7.23x | ₩8.73 Billion | ₩63.13 Billion | ▼ -27.8% |
| 2021 | 10.01x | ₩11.68 Billion | ₩116.98 Billion | ▼ -12.0% |
| 2020 | 11.37x | ₩4.60 Billion | ₩52.31 Billion | ▲ +232.4% |
| 2018 | 3.42x | ₩11.45 Billion | ₩39.17 Billion | ▲ +1284.1% |
| 2017 | 0.25x | ₩16.76 Billion | ₩4.14 Billion | ▼ -27.1% |
| 2016 | 0.34x | ₩9.47 Billion | ₩3.21 Billion | ▲ +245.5% |
| 2012 | 0.10x | ₩24.65 Billion | ₩2.42 Billion | ▼ -37.8% |
| 2011 | 0.16x | ₩15.34 Billion | ₩2.42 Billion | ▼ -6.2% |
| 2009 | 0.17x | ₩8.68 Billion | ₩1.46 Billion | ▼ -51.1% |
| 2008 | 0.34x | ₩5.99 Billion | ₩2.06 Billion | — |